Evidence map›Paper›PMID 31862314›Full record

ArticleMolecular therapy : the journal of the American Society of Gene Therapy2020

Upregulation of PUM1 Expression in Preeclampsia Impairs Trophoblast Invasion by Negatively Regulating the Expression of the lncRNA HOTAIR.

Yan Zhang, Xiao-Ying He, Shi Qin, Hui-Qin Mo, Xiao Li, Fan Wu, Jing Zhang, Xing Li, Lin Mao, Ya-Qing Peng and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular therapy : the journal of the American Society of Gene Therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. The Role of ncRNAs in the Immune Dysregulation of Preeclampsia.International journal of molecular sciences · 2023
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Roles of noncoding RNAs in preeclampsia.Reproductive biology and endocrinology : RB&E · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Single Nucleotide Polymorphisms inFrontiers in oncology · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Yan ZhangDepartment of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China.
Xiao-Ying HeShanghai Key Laboratory of Embryo Original Diseases, Shanghai, China; International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Shanghai Municipal Key Clinical Specialty, Shanghai, China.
Shi QinShanghai Key Laboratory of Embryo Original Diseases, Shanghai, China; International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Shanghai Municipal Key Clinical Specialty, Shanghai, China.
Hui-Qin MoShanghai Key Laboratory of Embryo Original Diseases, Shanghai, China; International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Shanghai Municipal Key Clinical Specialty, Shanghai, China.
Xiao LiShanghai Key Laboratory of Embryo Original Diseases, Shanghai, China; International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Shanghai Municipal Key Clinical Specialty, Shanghai, China.
Fan WuShanghai Key Laboratory of Embryo Original Diseases, Shanghai, China; International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Shanghai Municipal Key Clinical Specialty, Shanghai, China.
Jing ZhangShanghai Key Laboratory of Embryo Original Diseases, Shanghai, China; International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Shanghai Municipal Key Clinical Specialty, Shanghai, China.
Xing LiDepartment of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China.
Lin MaoDepartment of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China.
Ya-Qing PengDepartment of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China.
Yu-Na GuoShanghai Key Laboratory of Embryo Original Diseases, Shanghai, China; International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Shanghai Municipal Key Clinical Specialty, Shanghai, China.
Yi LinShanghai Key Laboratory of Embryo Original Diseases, Shanghai, China; International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Shanghai Municipal Key Clinical Specialty, Shanghai, China.
Fu-Ju TianShanghai Key Laboratory of Embryo Original Diseases, Shanghai, China; International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Shanghai Municipal Key Clinical Specialty, Shanghai, China. Electronic address: fjtian@sibs.ac.cn.
Shanghai Jiao Tong University · CNRenmin Hospital of Wuhan University · CNShanghai Municipal People's Government · CNInternational Peace Maternity & Child Health Hospital · CNWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pumilio (PUM) proteins are members of a highly conserved RNA-binding protein family that posttranscriptionally regulate gene expression in many organisms. However, their roles in the placenta are unclear. In the present study, we report the requirement for the PUM homolog 1 (PUM1) gene in preeclampsia (PE). Immunofluorescence and immunohistochemical data showed that PUM1 was highly expressed in human placental villi from women with PE compared to healthy controls (HCs). Further, PUM1 overexpression repressed, and knockdown enhanced, the invasion and proliferation of trophoblasts. Interestingly, PUM1 knockdown promoted trophoblast invasion in a villous explant culture model, while PUM1 overexpression repressed these effects. Furthermore, lncRNA transcriptome sequencing coupled with RNA immunoprecipitation (RIP) revealed that PUM1 inhibits trophoblast invasion in PE by downregulating the expression of lncRNA HOTAIR. Moreover, PUM1 regulates HOTAIR expression via a posttranscriptional mechanism. Using RNA-protein pull-down and mRNA stability assays, we identified PUM1 as a specific binding partner that decreased the half-life of HOTAIR and lowered the steady-state level of HOTAIR expression, suggesting a novel posttranscriptional regulatory mechanism. Collectively, these findings identified a novel RNA regulatory mechanism, revealing a new pathway governing the regulation of PUM1/HOTAIR in trophoblast invasion in the pathogenesis of PE.

Indexed as

Gene Expression RegulationCell LineCell MovementCell ProliferationCells, CulturedFemaleGene Expression ProfilingHumansImmunohistochemistryPre-EclampsiaPregnancyRNA-Binding ProteinsRNA, Long NoncodingRNA StabilityTrophoblastsHOTAIR long untranslated RNA, humanPUM1 protein, humanRNA-Binding ProteinsRNA, Long NoncodingHOTAIRlncRNA stabilitypreeclampsiaPUM1trophoblast invasion

Identifiers

PMID31862314
PMCPMC7001091
OpenAlexW2994339827

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.